Clinical Trial Update: Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating safety and efficacy in malignant rhabdoid tumors and neuroblastoma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Rhabdoid Tumors
• Neuroblastoma

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Malignant Rhabdoid Tumors (MRT), Neuroblastoma | Phase 1 | Status: TERMINATED | Results posted: 2019-02-28